In a bipartisan spending agreement that was largely negotiated behind closed doors, Congress included a policy change with ...
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more claims data on dispensed 340B drugs is onerous and unlawful.
The House Energy and Commerce Committee has advanced legislation that would have major impacts on payments in the 340B drug discount program, and providers are not pleased with the potential changes.
WCIA Champaign on MSN
Illinois faith leaders challenge hospitals over 340B Drug Program
SPRINGFIELD, Ill. (WCIA) — Faith and community leaders gathered in Springfield on Wednesday to call for increased oversight ...
The federal government is rolling back a pandemic-era waiver that lowered the bar for 340B hospitals to dispense discounted drugs across additional outpatient sites, a decision hospitals said will ...
Senator calls on Congress to increase oversight of the 340B Drug Pricing Program by requiring participating providers to complete annual reports on program savings and revenues. If your health system ...
Axios on MSN
Health care advocates say FSSA's proposed drug program change will erode Indiana's safety net
Indiana wants to discontinue Medicaid reimbursement for drugs purchased under a federal program designed to help hospitals ...
Despite the rancor, there are many bipartisan opportunities for the divided 118 th Congress. Near the top of the to-do list should be reforming the well-intentioned, but poorly designed, 340B drug ...
The 340B Program has continued to undergo significant upheaval in 2024 that has the potential to bring about impactful changes to how the 340B Program operates moving forward. These developments have ...
The Patient Protection and Affordable Care Act is expected to bring significant change to the healthcare industry, including the expansion of the Public Health Service Act Section 340B Program.
One of the critical components for Mainers as they navigate the medical quagmire of insurance, providers and treatment is obtaining effective and safe drugs. Cancer treatment is often a long, taxing ...
On March 17, 2026, the Ninth Circuit issued a unanimous decision in United States ex rel. Adventist Health Sys. of W. v. AbbVie Inc. allowing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results